Clinical Trials Browser

Interventional × lenzilumab × Clear all

NCT04534725 2023-08-24

C-SMART

Phase 3 Completed

COVID-19, Neoplasms

NCT02546284 2020-02-28

Study of Lenzilumab in Previously Treated Patients With Chronic Myelomonocytic Leukemia (CMML)

Phase 1 Completed

Other hematologic neoplasm

Leukemia, Myelomonocytic, Chronic